530 related articles for article (PubMed ID: 17601629)
1. Nanosizing--oral formulation development and biopharmaceutical evaluation.
Kesisoglou F; Panmai S; Wu Y
Adv Drug Deliv Rev; 2007 Jul; 59(7):631-44. PubMed ID: 17601629
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.
Fakes MG; Vakkalagadda BJ; Qian F; Desikan S; Gandhi RB; Lai C; Hsieh A; Franchini MK; Toale H; Brown J
Int J Pharm; 2009 Mar; 370(1-2):167-74. PubMed ID: 19100319
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles: A personal experience for formulating poorly water soluble drugs.
Cooper ER
J Control Release; 2010 Feb; 141(3):300-2. PubMed ID: 19822177
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers.
Torchilin VP
Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
[TBL] [Abstract][Full Text] [Related]
5. [Importance of particle size decrease in the preformulation].
Szunyogh T; Ambrus R; Szabóné RP
Acta Pharm Hung; 2011; 81(1):29-36. PubMed ID: 21595303
[TBL] [Abstract][Full Text] [Related]
6. Developing early formulations: practice and perspective.
Li P; Zhao L
Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles for parenteral drug delivery.
Wissing SA; Kayser O; Müller RH
Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
[TBL] [Abstract][Full Text] [Related]
8. In vitro - in vivo correlation: from theory to applications.
Emami J
J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use.
Limayem Blouza I; Charcosset C; Sfar S; Fessi H
Int J Pharm; 2006 Nov; 325(1-2):124-31. PubMed ID: 16872764
[TBL] [Abstract][Full Text] [Related]
10. Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate.
Dai WG; Dong LC; Song YQ
Int J Pharm; 2007 Sep; 342(1-2):201-7. PubMed ID: 17560055
[TBL] [Abstract][Full Text] [Related]
11. Leveraging elevated temperature and particle size reduction to extract API from various tablet formulations.
Nickerson B; Arikpo WB; Berry MR; Bobin VJ; Houck TL; Mansour HL; Warzeka J
J Pharm Biomed Anal; 2008 Jun; 47(2):268-78. PubMed ID: 18280688
[TBL] [Abstract][Full Text] [Related]
12. Nanodispersions of taxifolin: impact of solid-state properties on dissolution behavior.
Shikov AN; Pozharitskaya ON; Miroshnyk I; Mirza S; Urakova IN; Hirsjärvi S; Makarov VG; Heinämäki J; Yliruusi J; Hiltunen R
Int J Pharm; 2009 Jul; 377(1-2):148-52. PubMed ID: 19426789
[TBL] [Abstract][Full Text] [Related]
13. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.
Van Eerdenbrugh B; Van den Mooter G; Augustijns P
Int J Pharm; 2008 Nov; 364(1):64-75. PubMed ID: 18721869
[TBL] [Abstract][Full Text] [Related]
14. Nanosizing drug particles in supercritical fluid processing.
Pathak P; Meziani MJ; Desai T; Sun YP
J Am Chem Soc; 2004 Sep; 126(35):10842-3. PubMed ID: 15339159
[TBL] [Abstract][Full Text] [Related]
15. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
Deng Z; Xu S; Li S
Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in intravenous delivery of poorly water-soluble compounds.
Shi Y; Porter W; Merdan T; Li LC
Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
[TBL] [Abstract][Full Text] [Related]
17. Diverse approaches for the enhancement of oral drug bioavailability.
Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
[TBL] [Abstract][Full Text] [Related]
18. The utility of cyclodextrins for enhancing oral bioavailability.
Carrier RL; Miller LA; Ahmed I
J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
[TBL] [Abstract][Full Text] [Related]
19. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
20. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
Merisko-Liversidge E; Liversidge GG
Adv Drug Deliv Rev; 2011 May; 63(6):427-40. PubMed ID: 21223990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
